Shandong Sito Bio-technology Co Ltd
SZSE:300583
Shandong Sito Bio-technology Co Ltd
SZSE:300583
Price:
14.85
CNY
-0.54%
Market Closed
Market Cap:
¥2.8B
Relative Value
The Relative Value of one
Shandong Sito Bio-technology Co Ltd
stock under the Base Case scenario is
11.92
CNY.
Compared to the current market price of 14.85 CNY,
Shandong Sito Bio-technology Co Ltd
is
Overvalued by 20%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
11.92
CNY
Overvaluation 20%
Multiples Across Competitors
Competitors Multiples
Shandong Sito Bio-technology Co Ltd Competitors
Shandong Sito Bio-technology Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Shandong Sito Bio-technology Co Ltd
SZSE:300583
|
2.8B CNY | 3 | -16.3 | -18.9 | -18.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
983.7B USD | 15.1 | 47.7 | 32.1 | 34.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.8B USD | 6.2 | 21.9 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286.9B CHF | 4.7 | 30.6 | 12.9 | 15 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233.3B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
241.3B CHF | 5.5 | 22.2 | 13.7 | 17.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.7 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD | 2.6 | 17.5 | 6.8 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
